Plasma cells serve an important role in the acute response to infection and in the long-term protection of the host by providing humoral immunity through continuous secretion of antibodies 1 . Activation of B cells by antigen leads to their differentiation into short-lived, antibody-secreting plasmablasts, which can develop into quiescent long-lived plasma cells after migrating to survival niches in the bone marrow 1 . Plasmablast formation is associated with substantial changes in cell morphology and gene expression 1,2 . The rearranged locus encoding the immunoglobulin heavy chain (Igh) switches expression from its B cell-specific mRNA encoding the membranebound protein to the plasma cell-specific transcript encoding the secreted immunoglobulin heavy chain 1 . Moreover, the expression of Igh and genes encoding immunoglobulin light chains (Igk and Igl) is substantially increased in plasmablasts, which results in the secretion of large amounts of immunoglobulins 1,2 . To cope with this output, antibody-secreting cells greatly increase their secretory machinery by expanding the endoplasmic reticulum (ER). These changes are a consequence of the unfolded protein response (UPR), which is induced by protein overloading of the ER and restores the folding, processing and export of proteins that pass through the ER. The transcription factor XBP-1, which is activated by the UPR 3 , is a central regulator of the UPR gene-expression program 4 and, as a consequence, is essential for the secretion of immunoglobulins by plasma cells 5 .
Plasma cells serve an important role in the acute response to infection and in the long-term protection of the host by providing humoral immunity through continuous secretion of antibodies 1 . Activation of B cells by antigen leads to their differentiation into short-lived, antibody-secreting plasmablasts, which can develop into quiescent long-lived plasma cells after migrating to survival niches in the bone marrow 1 . Plasmablast formation is associated with substantial changes in cell morphology and gene expression 1, 2 . The rearranged locus encoding the immunoglobulin heavy chain (Igh) switches expression from its B cell-specific mRNA encoding the membranebound protein to the plasma cell-specific transcript encoding the secreted immunoglobulin heavy chain 1 . Moreover, the expression of Igh and genes encoding immunoglobulin light chains (Igk and Igl) is substantially increased in plasmablasts, which results in the secretion of large amounts of immunoglobulins 1, 2 . To cope with this output, antibody-secreting cells greatly increase their secretory machinery by expanding the endoplasmic reticulum (ER). These changes are a consequence of the unfolded protein response (UPR), which is induced by protein overloading of the ER and restores the folding, processing and export of proteins that pass through the ER. The transcription factor XBP-1, which is activated by the UPR 3 , is a central regulator of the UPR gene-expression program 4 and, as a consequence, is essential for the secretion of immunoglobulins by plasma cells 5 .
While plasmablasts are generated in the absence of XBP-1 (ref. 6 ), their differentiation depends on the transcription factors IRF4 (ref. 7) and Blimp-1 (ref. 8) . IRF4 initiates plasmablast differentiation by activating Prdm1 (which encodes Blimp-1) 9, 10 . Blimp-1 is a Krüppel-type zinc-finger protein 11 that is able to induce plasmacytic differentiation upon its ectopic expression in mature B cells 12 . Within the B lymphoid lineage, Blimp-1 is expressed exclusively in antibodysecreting cells 13 that are lost in mice with B cell-specific deletion of Prdm1, which demonstrates an essential role for Blimp-1 in plasma cell generation 8 . However, Blimp-1 is not required for the initiation of plasmablast formation, as its loss arrests differentiation at the pre-plasmablast stage 14 .
Blimp-1 is a transcriptional repressor that silences the B cell gene-expression program in plasma cells 15 . Consistent with that, Blimp-1 interacts with co-repressors such as the histone H3K4 demethylase LSD1 (ref. 16 ), the histone H3K9 methyltransferase G9a 17 , the Groucho family proteins 18 and histone deacetylases 19 . So far, only five genes, encoding the transcription factors c-Myc 20 , Pax5 (ref. 21 ), CIITA 15, 22 , SpiB 15 and Id3 (ref. 15) , have been considered to be directly repressed by Blimp-1. Moreover, all Blimp-1-dependent gene-expression changes have been identified thus far by gain-of-function experiments in human and mouse B cell lines that ectopically expressed 23) . However, such experiments have been unable to distinguish between direct effects of Blimp-1 activity and its indirect effects and, furthermore, were performed in B cells rather than plasmablasts 15, 23 . Hence, little is known about the molecular mechanisms by which Blimp-1 controls plasma cell differentiation. Here we comprehensively analyzed the molecular role of Blimp-1 at the onset of plasmablast differentiation A r t i c l e s and found that Blimp-1 directly controls many essential functions of plasmablasts and plasma cells.
RESULTS

Blimp-1-dependent gene expression in plasma cells
To study the molecular function of Blimp-1, we first defined the geneexpression changes occurring during the differentiation of activated B cells into plasmablasts. We obtained cells from Prdm1 gfp/+ mice (heterozygous for expression of a green fluorescent protein (GFP) reporter expressed from Prdm1) 13 for these studies. After being stimulated for 4 d with lipopolysaccharide (LPS), B220 + B cells from the spleen and lymph nodes of Prdm1 gfp/+ mice differentiated into activated B cells (CD138 − GFP − CD22 + CXCR4 − ), immunoglobulin-secreting preplasmablasts (CD138 − GFP + CD22 − CXCR4 + ) and plasmablasts (CD 138 + GFP + CD22 − CXCR4 + ) 14 ( Fig. 1a and Supplementary Fig. 1a ), which we subsequently subjected to RNA-sequencing (RNA-seq) analysis. Genes were identified as 'differentially expressed' in all RNA-seq comparisons if they had a difference in expression of above threefold, an adjusted P value of <0.1 and an RPKM value (reads per kilobase of exon per million mapped sequence reads) of >3 in one of the two cell populations. Thus, 648 genes were upregulated and 424 genes were downregulated in the B cell-to-plasmablast transition ( Fig. 1b and Supplementary Table 1) . Most of the regulated genes were expressed similarly in pre-plasmablasts and plasmablasts (Supplementary Fig. 1b) . RNA-seq comparison of quiescent plasma cells from the bone marrow with non-proliferating mature B cells from lymph nodes (Supplementary Fig. 1c ) identified 1,260 genes that were upregulated and 900 genes that were downregulated in plasma cells relative to their expression in follicular B cells ( npg genes and 274 (65%) of the downregulated genes in in vitrodifferentiated plasmablasts were regulated similarly in plasma cells in vivo (Fig. 1d) .
To identify the Blimp-1-dependent part of the plasmablast expression signature, we used a transgenic line expressing Cre recombinase from the B cell-specific promoter of the gene encoding CD23 (Cd23-Cre) 24 to delete the loxP-flanked Prdm1 allele (Prdm1 fl ) 25 in B cells of Prdm1 gfp/fl Cd23-Cre mice, which additionally carried the Prdm1 gfp null allele 13 . Prdm1 gfp/fl Cd23-Cre B cells induced to differentiate by treatment with LPS for 4 d gave rise to activated B cells, pre-plasmablasts and plasmablasts (Fig. 1e) , although the small plasmablast population still retained the intact Prdm1 fl allele (Supplementary Fig. 1d ), consistent with a stringent requirement for Blimp-1 in plasmablast formation 8, 14 . As the pre-plasmablast population consisted of a mixture of cells containing either the intact Prdm1 fl allele or the deleted Prdm1 allele (Prdm1 ∆ ) (Supplementary Fig. 1d ), we used expression of the gene encoding the lectin CD22, which is repressed by Blimp-1 (Fig. 1a,e) , to fractionate the cell mixture into CD22 + CD138 − GFP + pre-plasmablasts with deletion of Prdm1 (Prdm1 gfp/∆ ) and CD22 − CD138 − GFP + pre-plasmablasts expressing Prdm1 (Prdm1 gfp/fl ) ( Supplementary Fig. 1d,e) . RNA-seq comparison of Prdm1 gfp/∆ and Prdm1 gfp/+ pre-plasmablasts identified 278 genes activated by Blimp-1 and 257 genes repressed by Blimp-1 in pre-plasmablasts ( Fig. 1f and Supplementary Table 3) . As 245 genes were also upregulated and 173 genes were downregulated during the B cell-to-plasmablast transition, we regarded these as relevant Blimp-1-regulated genes (Fig. 1g) . Hence, Blimp-1 activated 38% (245) of all upregulated genes (648) and repressed 41% (173) of all downregulated genes (424) during plasmablast differentiation. (Fig. 1h,  Supplementary Fig. 1f and data not shown). This revealed a major Blimp-1-dependent change in the expression and thus the signaling of cell-surface receptors during terminal B cell differentiation.
A r t i c l e s
Blimp-1-dependent genes were similarly expressed in Blimp-1-negative (GFP − ) activated B cells (Prdm1 gfp/+ ) and Blimp-1-deficient (GFP + ) pre-plasmablasts (Prdm1 gfp/∆ ) ( Fig. 1h and Supplementary  Fig. 1f ), which suggested that the loss of Blimp-1 might have arrested differentiation at the activated B cell stage. However, 77 genes were normally activated or repressed during the B cell-to-pre-plasmablast transition in the absence of Blimp-1, as exemplified by the activated genes Rgs10, Socs2, Top1, Tubb6, Slamf7 and Cdkn2b and the repressed genes Bach2, Ccr6, Il12a and Irf8 ( Fig. 1i and Supplementary Fig. 1g ). This provided molecular evidence that the loss of Blimp-1 arrested differentiation at the pre-plasmablast stage. Collectively, these data demonstrated that Blimp-1 controlled a large part of the geneexpression changes associated with plasma cell differentiation.
Identification of regulated Blimp-1 target genes
To assess the genome-wide binding pattern of Blimp-1, we generated a Prdm1 Bio allele by inserting sequence encoding a biotin-acceptor motif (Bio) at the final codon of Prdm1 (Supplementary Fig. 2a,b) .
The resultant Blimp-1-Bio protein was efficiently biotinylated by the Escherichia coli biotin ligase BirA expressed from the ubiquitous Rosa26 locus (Rosa26 BirA ) in LPS-stimulated Prdm1 Bio/ Bio Rosa26 BirA/+ plasmablasts, which facilitated streptavidin-mediated precipitation of Blimp-1-Bio (Supplementary Fig. 2c ). Notably, Prdm1 Bio/Bio Rosa26 BirA/BirA mice had normal B cell development and immune responses at day 14 after immunization with nitrophenyl coupled to keyhole limpet hemocyanin ( Supplementary  Fig. 2d-f) , which indicated that the carboxy-terminal insertion did not affect Blimp-1's function. We next analyzed LPS-induced CD138 + plasmablasts of the Prdm1 Bio/Bio Rosa26 BirA/BirA genotype by streptavidin-mediated chromatin precipitation coupled with deep sequencing (Bio-ChIP-seq) 26 (Fig. 2a) . Peak calling with a stringent P value of < 10 −10 identified 8,742 Blimp-1-binding regions, which defined 4,899 Blimp-1 target genes in plasmablasts (data not shown). Analysis of the Blimp-1 peak sequences with de novo motifdiscovery programs identified a Blimp-1-binding motif (Fig. 2b) that resembled the published Blimp-1-recognition sequence 27 and was present at a high frequency (70%) at Blimp-1 peaks in plasmablasts (data not shown). By determining the overlap between the 4,899 Blimp-1-bound genes and the Blimp-1-regulated genes noted above (Fig. 1g) , we identified 93 potentially directly activated and 121 npg potentially directly repressed Blimp-1 target genes that were regulated more than threefold by Blimp-1 in pre-plasmablasts ( Fig. 2c and Supplementary Table 4 ). We present RNA expression and Blimp-1 binding for Aicda as a repressed target and for Il10, Mzb1, Hspa5 (which encodes BiP) and Ssr2 as activated targets ( Fig. 2d and Supplementary Fig. 2g ).
The data above suggested a previously unknown function for Blimp-1 as a transcriptional activator in addition to its known role in gene repression 11, 15 . To investigate whether Blimp-1 directly activates gene transcription, we generated a post-translational induction system by fusing the full-length Blimp-1 protein at its carboxyl terminus to the ligand-binding domain of a mutant estrogen receptor (ER T2 ) that interacts only with the estrogen analog 4-hydroxytamoxifen (OHT) 28 . We infected the mouse B cell line WEHI-231 with the retroviral vector MiCD2 expressing Blimp-1-ER T2 (WEHI-Blimp-1-ER T2 cells) and selected single-cell clones that efficiently repressed the Blimp-1 target gene Cd22 after treatment with OHT ( Supplementary  Fig. 2h ). The addition of OHT to WEHI-Blimp-1-ER T2 cells for 6 h led to a two-to fourfold increase in the transcription of 14 activated target genes, as revealed by analysis of nascent transcripts by reverse transcription followed by quantitative PCR (RT-qPCR) (Fig. 2e) . As the Blimp-1-ER T2 protein is constitutively expressed in an inactive form in WEHI-Blimp-1-ER T2 cells, it can be activated by the addition of OHT even in the presence of the translation inhibitor cycloheximide, which prevents indirect transcriptional effects. Under these conditions, Blimp-1-ER T2 was still able to induce transcription of all 14 genes within 6 h of treatment with OHT (Fig. 2e) . As shown by chromatin immunoprecipitation (ChIP) followed by quantitative PCR (ChIP-qPCR), the active histone mark H3K4me2 was induced in WEHI-Blimp-1-ER T2 cells within 2 h, and the abundance of the active histone mark H3K27ac was increased at Blimp-1-binding sites of four activated target genes at 2 or 6 h after the addition of OHT (Fig. 2f) . Hence, the Blimp-1-ER T2 -induction system provided clear evidence that Blimp-1 was able to directly activate its target genes at the level of both transcription and chromatin. Notably, the Blimp-1-binding sites at repressed target genes rapidly lost H3K27ac within 2 h and gained the repressive H3K27me3 modification with a delay at 6-12 h after the induction of Fig. 4d ) and of the binding of Blimp-1 to the Tram1 locus in Prdm1 Bio/Bio Rosa26 BirA/BirA plasmablasts, with IRF4, PU.1 and Blimp-1 peaks called at a stringent P value of <10 −10 . (b) Colocalization of Blimp-1 peaks with binding sites of IRF4 and PU.1 in plasmablasts, as determined by multiple overlap analysis of the respective ChIP-seq data, presented relative to the total Blimp-1-binding sites (8, 742) or the Blimp-1-binding sites present at activated and repressed Blimp-1 target genes (Fig. 2c) . Numbers in bars indicate the frequency of peaks in each group (right margin); numbers above bars indicate total peaks in each category. (c) Consensus motif of the common binding sites for Blimp-1 and the PU.1-IRF4 complex (middle), identified bioinformatically by strict colocalization of the Blimp-1-binding motif and EICE in the 3,806 peaks characterized by overlapping binding of Blimp-1, IRF4 and PU.1 ( Supplementary Fig. 4a ), presented alongside the Blimp-1-only motif (top) and EICE (bottom) ( Supplementary Fig. 4a) ; asterisks indicate deviation from the common motif (black (Blimp-1-only) or red (EICE)). (Fig. 2g) , which indicated that histone deactylation preceded H3K27 methylation at the repressed target genes. In summary, these data indicated that Blimp-1 was also able to function as a transcriptional activator, in addition to its known role as a repressor.
Functions of proteins encoded by Blimp-1 target genes
The target genes regulated by Blimp-1 encoded proteins of distinct functional classes (Fig. 3a and Supplementary Table 4) . Half of all repressed Blimp-1 target genes encoded products in the following categories (proportion of the repressed target genes in parentheses): 32 signal transducers (26%), 16 cell surface receptors (13%) and 13 transcriptional regulators (11%) (Fig. 3a) , which indicated that Blimp-1 might suppress B cell signaling in plasmablasts. The functions of the proteins encoded by these repressed target genes linked Blimp-1 to the suppression of signaling via B cell antigen receptors and Toll-like receptors, antigen presentation and T cell co-stimulation, class-switch recombination and somatic hypermutation, as well as cell adhesion and migration ( Fig. 3a and Supplementary Fig. 3 ). Blimp-1 activated fewer genes encoding proteins in the following categories (proportion of the activated target genes in parentheses): 15 signal transducers (16%), 7 cell-surface receptors (7.5%) and 7 transcriptional regulators (7.5%) (Fig. 3a) . Notably, we identified 9 activated target genes and 21 repressed target genes encoding cell-surface proteins, signal transducers and cytoskeletal proteins involved in cell adhesion and migration ( Fig. 3a  and Supplementary Fig. 3) , which suggested that Blimp-1 controls the migratory and sessile behavior of plasmablasts 29, 30 . In Transwell migration assays, control (Prdm1 gfp/+ ) pre-plasmablasts migrated faster than activated B cells toward the chemokine CXCL12 (SDF-1α) (Fig. 3b) . However, this enhanced migration was not observed for Blimp-1-deficient (Prdm1 gfp/∆ ) pre-plasmablasts, although Cxcr4 (which encodes the receptor for CXCL12) was expressed similarly in preplasmablasts of both genotypes (data not shown). In the presence of CXCL12, the control (Prdm1 gfp/+ ) pre-plasmablasts also adhered better than Blimp-1-deficient (Prdm1 gfp/∆ ) pre-plasmablasts to surfaces coated with the adhesion molecules ICAM-1 or VCAM-1 (Fig. 3c) . Hence, Blimp-1 enhanced both the migration and substrate adhesion of the plasmablasts. In addition, the plasmablasts communicated with their environment by secreting the growth factor VEGF-A, the signaling molecule Wnt10a and interleukin 10, as shown by Blimp-1-activated expression of the respective genes (Supplementary Fig. 3) . Plasmablasts also expressed, in a Blimp-1-dependent manner, Tigit, Clta4, Tmem66 and Lag3, which encode inhibitory cell-surface receptors with known functions in T cells (Fig. 3 and Supplementary Fig. 3) .
Notably, 78 Blimp-1-activated genes encoded proteins linked to ER stress control and immunoglobulin secretion (data not shown). Blimp-1 binding was absent at 58 of these genes, which were probably controlled by the UPR regulator XBP-1 (data not shown). However, Blimp-1 bound to and activated 20 genes encoding proteins linked to ER function and ER stress control in plasmablasts ( Fig. 3a and Supplementary Fig. 3 ), of which five (Derl1, Mzb1, Ssr2, Tram2 and Cnst) were directly activated in WEHI-Blimp-1-ER T2 cells (Fig. 2e) . Hence, Blimp-1, in addition to XBP-1, might directly contribute to the regulation of immunoglobulin secretion.
Blimp-1-dependent transcriptional network in plasmablasts IRF4, another essential plasma cell transcription factor 7 , binds with the Ets transcription factor PU.1 to the Ets-IRF composite element (EICE) 31 , which resembles the Blimp-1 motif. This similarity suggests that IRF4 and Blimp-1 might bind the same recognition sequence. To test this hypothesis, we assessed the binding of IRF4 and PU.1 in plasmablasts by ChIP followed by deep sequencing (ChIP-seq), which identified 19,735 IRF4 peaks and 39,772 PU.1 peaks, respectively (Fig. 4a) . Colocalization of PU.1, IRF4 and Blimp-1 peaks (Supplementary Fig. 4a ) revealed that most Blimp-1-binding regions in the genome (45%) and at regulated target genes (52%) overlapped PU.1 and IRF4 peaks (Fig. 4b) . Sorting of a heat map containing all 3,806 common peaks according to the IRF4 peak density demonstrated that the PU.1-binding densities and IRF4-binding densities largely correlated with each other (Supplementary Fig. 4b) , consistent with the presence of the EICE (Supplementary Fig. 4a ). However, sorting for the Blimp-1-binding density revealed no correlation with either IRF4 peaks or PU.1 peaks (Supplementary Fig. 4b) , which suggested that the binding of Blimp-1 was independent of the binding of PU.1 and IRF4. However, the Blimp-1 motif and EICE were often colocalized at the same position, which contained a common binding motif that deviated at several positions from the Blimp-1 motif and the EICE (Fig. 4c ). An electrophoretic mobility-shift assay demonstrated that Blimp-1 and the PU.1-IRF4 complex were able to bind to the common binding motif present at the repressed target genes Vrk2 (intron 2; Fig. 4d ) and Tlr9 (intron 1; data not shown). 'Super-shift' experiments with specific antibodies revealed that the Blimp-1 complex was distinct from complexes containing PU.1 and IRF4 (Fig. 4d) . Hence, Blimp-1 and the PU.1-IRF4 complex were able to bind to the same sequence motif, although in a mutually exclusive manner. Consequently, ChIP-qPCR experiments demonstrated that (Fig. 4e and Supplementary Fig. 4c ). Blimp-1 activated 7 and repressed 13 transcription factor-encoding genes (Fig. 5) , which contained one or multiple Blimp-1-binding site(s) in plasmablasts (Supplementary Fig. 5a,b) , consistent with direct regulation by Blimp-1. Our analysis revealed the entire Blimp-1-binding profile at the Ciita 22 (Supplementary Fig. 5a ), which were previously considered to be loci silenced by Blimp-1. The other 9 Blimp-1-repressed transcription factor-encoding genes were not previously associated with regulation by Blimp-1 and encoded a co-repressor (Tle3), a transcription-elongation factor (Aff3), three transcription factors with unknown B cell function (Dek, Irf2bp2 and Zeb2), and four regulators that control important aspects of B cell development (Bcl11a 32 , Gfi1b 33 , Hhex 34 and Klf2 (ref. 35) ). Notably, Bcl6, which encodes an essential regulator of germinal center B cells, contained several Blimp-1-binding sites ( Supplementary  Fig. 5c ), consistent with its known Blimp-1-dependent repression 15 , although we failed to identify Bcl6 as a Blimp-1-repressed gene, due to its low expression in activated B cells (Fig. 5c) . Of the 7 transcription factors encoded by Blimp-1-activated genes, only IRF4 and ELL2 have known roles in plasma cell differentiation 7, 9 and immunoglobulin secretion [36] [37] [38] , respectively. Moreover, the activated target gene Eaf2 encodes a positive regulator of the transcription-elongation activity of ELL2 (ref. 39 ).
In conclusion, we found that Blimp-1 contributed to the transcriptional network of plasma cells by regulating multiple transcription factor-encoding genes.
Activation of immunoglobulin transcription by Blimp-1 XBP-1, an essential regulator of the UPR gene-expression program 4, 5 , acts downstream of Blimp-1 in the regulatory cascade of terminal B cell differentiation 4, 6 . Our RNA-seq data, combined with RT-qPCR analysis of nascent transcripts, demonstrated an essential role for Blimp-1 in the substantial upregulation of Xbp1 transcription in pre-plasmablasts compared with its transcription in activated B cells (Fig. 5d,e) . However, the Xbp1 locus was devoid of Blimp-1-binding Fig. 5d ), which suggested that Xbp1 was indirectly activated by Blimp-1. Furthermore, RNA-seq analysis revealed a greater abundance of Igh and Igk mRNA in control pre-plasmablasts (20 times as much Igh and 13 times as much Igk) and plasmablasts (29 times as much Igh and 18 times as much Igk) than in activated B cells (Fig. 6a,b and Supplementary  Fig. 6a ). This robust increase in mRNA was caused by transcriptional activation, as a similar increase in nascent Igh and Igk transcripts was detected by RT-qPCR analysis (Fig. 6c) . Consequently, mRNA encoding the secreted forms of IgM, IgG2b and IgG3 underwent a considerable increase during terminal B cell differentiation, in contrast to the constant expression of mRNA encoding the membrane-bound form of IgM (Fig. 6d,e) .
In the absence of Blimp-1, Igh mRNA and Igk mRNA and the respective nascent transcripts underwent only a minimal increase (Fig. 6a-c) , and the post-transcriptional switch to mRNA encoding the secreted form of IgM, IgG2b or IgG3 did not take place in Blimp-1-deficient pre-plasmablasts (Fig. 6d,e) . npg mRNA isoforms encoding the secreted immunoglobulin heavy chain in plasmablasts.
High expression of Igh in plasma cells depends on the 3′ regulatory region (3′ RR), which consists of four enhancers (HS1/2, HS3A, HS3B and HS4) at the 3′ end of the Igh locus 40 . Mapping of open chromatin regions (also known as 'DNase I-hypersensitive sites' (DHSs)) by the assay for transposase-accessible chromatin with high-throughput sequencing (ATAC-seq) 41 revealed that all four enhancers were already present in open chromatin in activated B cells (Fig. 6f) . In contrast, the accessibility at HS3A and HS3B was much lower in Blimp-1-deficient pre-plasmablasts than in Blimp-1-expressing preplasmablasts, although the density at all genomic DHSs was similar in both cell types (Supplementary Fig. 6c,d) . Blimp-1 bound only to the enhancer HS1/2, whereas IRF4 interacted with all four enhancers, and PU.1 interacted only with HS4 in the 3′ RR (Fig. 6f) . These data therefore indicated that Blimp-1 was indirectly responsible for maintaining open chromatin at the 3′ RR in plasmablasts. The loss of Blimp-1 also resulted in diminished chromatin accessibility of all enhancers at the 3′ end of the Igk locus in pre-plasmablasts, although Blimp-1 bound only weakly to the enhancer iEκ and a newly identified plasmablast-specific DHS (Supplementary Fig. 6b) . Hence, Blimp-1 contributed to the transcriptional activation of Igh and Igk as well as to the post-transcriptional mRNA switch that leads to expression of the secreted immunoglobulin heavy chain in plasma cells.
Chromatin changes at regulated Blimp-1 target genes
In addition to mapping DHSs, we mapped active histone marks (H3K4me2, H3K4me3, H3K9ac) and repressive histone marks (H3K27me3) by ChIP-seq in Prdm1 gfp/+ activated B cells and plasmablasts at day 4 of LPS stimulation (Supplementary Fig. 7a,b) . We defined 'active' promoters by the presence of a DHS (identified by ATAC-seq) at an mm9-annotated transcription start site (TSS) and 'active' distal elements (potential enhancers) by the presence of a DHS in the absence of a TSS. In plasmablasts, 15.4% (1,349) of all Blimp-1-binding sites (8, 742 ) were located at 'active' promoters (with a DHS and a TSS), which were embedded in active chromatin (86%) or bivalent chromatin (14%) (Fig. 7a and Supplementary  Fig. 7b 
npg
A r t i c l e s distal elements (with a DHS but no TSS), which carried active chromatin (56%), poised chromatin (11%) or bivalent chromatin (26%) (Fig. 7a) . Hence, Blimp-1 bound mainly to active promoters and distal elements in plasmablasts. Notably, many Blimp-1 peaks (37.3%; 3,265) were also located at less-accessible genomic regions (without a DHS or TSS) ( Fig. 7a and Supplementary Fig. 7b ).
The histone modifications analyzed did not change during the B cell-to-plasmablast transition at the Blimp-1-binding sites of genes that were not regulated by Blimp-1 (Fig. 7d) . The abundance of all three active histone marks, however, was greater at the Blimp-1-binding sites of activated target genes in plasmablasts than at those in activated B cells (Fig. 7b,d) . In contrast, the three active chromatin modifications were lower at Blimp-1-binding sites of repressed target genes in plasmablasts than at those of activated B cells (Fig. 7c,d) . Notably, the repressive modification H3K27me3 was present only in plasmablasts at the Blimp-1-binding sites of repressed target genes, where it spread in both directions (Fig. 7c,d,f) . However, no increase in the abundance of H3K27me3 was detected in plasmablasts compared with its abundance in activated B cells at the DHSs of genes that were repressed in plasmablasts but lacked Blimp-1-binding sites (Supplementary Fig. 7c) . Notably, ChIP-seq analysis of preplasmablasts revealed that H3K27me3 was absent at the Blimp-1-binding sites of repressed target genes in Blimp-1-deficient pre-plasmablasts, in contrast to its presence in Blimp-1-expressing pre-plasmablasts ( Fig. 7e,f; Supplementary Fig. 7d ). These data suggested that Blimp-1 was involved in recruiting the H3K27-methylating Polycomb repressive complex 2 (PRC2) 42 to its repressed target genes in plasmablasts. A prevailing model predicts, however, that the recruitment of Polycomb complexes to DNA occurs by default at CpG islands lacking active chromatin rather than by DNA-binding proteins 43 . Contrary to that model, the Blimp-1-binding sites of repressed target genes did not show any enrichment for CpG islands (as mapped by CXXC affinity purification with deep sequencing in mouse blood cells 44 ), in contrast to their enrichment at the Blimp-1-binding sites of non-regulated and activated target genes ( Fig. 7b-d) . Moreover, Blimp-1-binding sites displaying bilateral H3K27me3 spreading also did not show enrichment for CpG islands (Supplementary Fig. 7e ). Blimp-1-dependent spreading of H3K27me3 in the absence of a CpG island is shown for a Blimp-1-binding site in intron 6 of Pax5 (Fig. 7f) and intron 2 of Vrk2 (Supplementary Fig. 7f ), which furthermore demonstrated that other Blimp-1-binding sites at these repressed genes were not associated with H3K27me3 + chromatin. Hence, the binding of Blimp-1 was able to induce, in a context-dependent but CpG islandindependent manner, the spreading of H3K27me3 at repressed target genes in plasmablasts.
Recruitment of chromatin modifiers and remodelers by Blimp-1
To investigate a possible interaction of Blimp-1 with PRC2, we performed streptavidin precipitation experiments with nuclear extracts of LPS-stimulated Prdm1 Bio/Bio Rosa26 BirA/+ and Prdm1 +/+ Rosa26 BirA/+ plasmablasts. Ezh2, the catalytic subunit of PRC2 (ref. 42) , was specifically precipitated together with biotinylated Blimp-1-Bio (Fig. 8a) . We verified that interaction in HEK-293T human embryonic kidney cells transiently transfected with expression vectors encoding BirA, V5-tagged Blimp-1-Bio and Myc-tagged Ezh2 or IRF4. Streptavidin precipitation of nuclear extracts revealed that in contrast to Myctagged IRF4, Myc-tagged Ezh2 was specifically precipitated together with Blimp-1-Bio (Fig. 8b) . Moreover, Blimp-1-Bio was precipitated together with Myc-tagged Ezh2 (Fig. 8c) by co-immunoprecipitation with a Myc-specific antibody.
We next investigated the role of PRC2 in Blimp-1-mediated gene repression by adding GSK343, a small-molecule inhibitor of Ezh2, to Prdm1 gfp/+ B cells at the start of LPS-induced plasmablast differentiation. RNA-seq analysis of pre-plasmablasts treated with GSK343 or the control reagent DMSO demonstrated that many repressed Blimp-1 target genes were partially silenced after inhibition of Ezh2, which prevented methylation of H3K27 (Supplementary Fig. 8a,b) . The incomplete repression observed was consistent with a role for PRC2 in maintaining the silenced expression state initially brought about by histone deacetylases and demethylases 42 (Fig. 2g) .
We used mass spectrometry to assess proteins precipitated by streptavidin from nuclear extracts of Prdm1 Bio/Bio Rosa26 BirA/+ plasmablasts and identified nine components of the chromatinremodeling BAF complex 45 (BAF45D, BAF47, BAF53A, BAF57, BAF60A, BAF60B, BAF155, BAF170 and Brg1), three subunits of the nucleosome-remodeling NuRD complex 45 (GATAD2A, MTA1 and CHD4 (Mi-2β)), three proteins of the NCoR complex 46 (TBL1, TBLR1 and NCOR1) and two factors of the SIN3 co-repressor complex 46 (SAP18 and SIN3A) (data not shown). We confirmed these interactions by precipitating Blimp-1-Bio from plasmablast extracts together with Brg1 (BAF), CHD4 (NuRD), MBD3 (NuRD), SIN3A (SIN3) and the histone deacetylase HDAC1 (Fig. 8d) , which is a component of the NuRD, NCoR and SIN3 complexes 46 . Hence, in addition to interacting with PRC2, Blimp-1 was able to interact with the chromatin-remodeling BAF and NuRD complexes as well as with the histone-deacetylating NCoR and SIN3 co-repressor complexes.
The Blimp-1-ER induction system is ideal for studying the recruitment of Blimp-1-interacting complexes to Blimp-1 target genes, as the ligand OHT prevents the binding of co-regulators to the ER ligand-binding domain by inducing an inactive conformation 47 . We thus stimulated WEHI-Blimp-1-ER T2 cells with OHT for a short time (up to 2 h), followed by ChIP-qPCR analysis with antibodies that detect specific subunits of the Blimp-1-interacting complexes. Within 30 min of treatment with OHT, Blimp-1-ER T2 interacted with its binding sites at repressed and activated target genes (Fig. 8e,f) . However, it was unable to bind to the promoter of the control gene Cd19 and thus failed to recruit HDAC1, Ezh2, CHD4, NCOR1 or Brg1 to Cd19 (Supplementary Fig. 8c ). In contrast, HDAC1 started to accumulate, within 1 h of the addition of OHT, at the Blimp-1-binding sites of the repressed target genes Spib, Aff3 and Kynu, in contrast to its lack of accumulation at Tlr9 and Il10ra (Fig. 8e) . Within 1 h of treatment with OHT, Brg1, CHD4 and NCOR1 were recruited to the Blimp-1-binding sites of all five repressed target genes, and Ezh2 was recruited to those sites within 2 h of treatment with OHT (Fig. 8e) . As the BAF complex can function as either a co-activator or a co-repressor 45 , Blimp-1 was able to recruit this complex, but not HDAC1, to its binding sites at the activated target genes Gnaz, Pik3cg and Tram2 (Fig. 8f) . Hence, Blimp-1 recruited chromatin-remodeling complexes (BAF and NuRD) and chromatinmodifying complexes (NCoR, NuRD and PRC2) to regulate its target genes in plasmablasts.
DISCUSSION
Blimp-1 is an essential regulator of plasma cell development 11 , yet little is known about its molecular functions in terminal B cell differentiation. Previous attempts to identify Blimp-1-regulated genes failed largely because of their experimental design, as differential gene expression was analyzed in mature B cell lines ectopically expressing Blimp-1 rather than in plasmablasts 15, 23 . Here we compared Blimp-1-deficient and Blimp-1-sufficient pre-plasmablasts by RNA-seq and found that Blimp-1 controlled a large part (~40%) npg A r t i c l e s of the gene-expression changes that occurred during the B cell-to-plasmablast transition. Notably, several genes that were activated or repressed during this developmental transition were regulated normally in Blimp-1-deficient pre-plasmablasts, which provided molecular evidence that the loss of Blimp-1 blocks differentiation at the pre-plasmablast stage 14 . By combining analysis of Blimp-1-mediated regulation with analysis of Blimp-1 binding, we identified a plethora of activated and repressed Blimp-1 target genes, which provided novel insight into the molecular functions of Blimp-1 in controlling plasma cell differentiation.
Blimp-1 is considered a dedicated transcriptional repressor 11 , yet our analysis identified 93 activated Blimp-1 target genes. Here we provided several lines of evidence that Blimp-1 can function as a transcriptional activator. First, stimulation of Blimp-1 activity in WEHI-Blimp-1-ER T2 cells rapidly induced the transcription of activated target genes even when protein synthesis was inhibited. Second, activation of Blimp-1 rapidly increased active histone modifications at the Blimp-1-binding sites of activated target genes in WEHI-Blimp-1-ER T2 cells. Third, active histone marks were also increased at Blimp-1-binding sites of activated target genes in plasmablasts. Fourth, Blimp-1 interacted in plasmablasts with the chromatin-remodeling BAF complex that functions as a transcriptional coactivator 45 . Finally, Blimp-1 rapidly recruited the BAF complex to binding sites at activated target genes in WEHIBlimp-1-ER T2 cells. Notably, an interesting class of activated Blimp-1 target genes encode proteins involved in ER function and protein secretion. Hence, Blimp-1, in addition to XBP-1, contributes to regulation of the UPR in plasmablasts and plasma cells.
Whereas published analyses of Blimp-1's role in the control of immunoglobulin secretion have yielded conflicting results 8, 14 , our study has revealed an essential role for Blimp-1 in the control of the post-transcriptional switch from the membrane-bound form of the immunoglobulin heavy chain to its secreted form. This Blimp-1-dependent switch can probably be explained by upregulation of the activated Blimp-1 targets Ell2 and Eaf2 in plasmablasts. ELL2, together with its partner protein EAF2, increases the transcription-elongation rate of RNA polymerase II (ref. 39 ). In the context of Igh expression, ELL2 promotes the generation of mRNA encoding the secreted form of the immunoglobulin heavy chain by changing the alternative processing of Igh transcripts at their 3′ end [36] [37] [38] . Notably, Blimp-1 also contributes to the biosynthesis and polymerization of secreted IgM in the ER by activating expression of the hexameric lectin LMAN1 (ref. 48 ) and the two interacting ER-resident chaperones HSP90B1 and MZB1 (ref. 49) .
In addition to controlling the processing of Igh mRNA, Blimp-1 substantially activated the transcription of Igh and Igk during the B cell-to-plasmablast transition. All four enhancers in the 3′ RR of the Igh locus have been linked to the substantial upregulation of Igh transcription in plasmablasts 40 , and, consistent with that, the loss of Blimp-1 diminished chromatin accessibility at two of these enhancers (HS3A and HS3B) in pre-plasmablasts. However, Blimp-1 bound only to the enhancer HS1/2 that is dispensable for abundant immunoglobulin secretion 50 , which suggests that Blimp-1 indirectly regulates the activity of the 3′ RR. Similarly, Blimp-1 indirectly controlled the chromatin accessibility of all 3′ enhancers in the Igk locus.
We also identified the full spectrum of repressed Blimp-1 target genes in plasmablasts. This analysis substantially extended published data by demonstrating that the genes encoding the transcription factors Pax5 (ref. 21 ), CIITA 15, 22 , SpiB 15 and Id3 (ref. 15) were directly repressed by Blimp-1 in plasmablasts. The mutual antagonism of Pax5 and Blimp-1 in late B cell development is of particular interest, as Pax5 maintains the identity of mature B cells 51 , whereas Blimp-1 enforces the plasmablast cell fate 8, 14 . Contrary to its essential role at the onset of plasmablast differentiation 8, 14 , Blimp-1 is dispensable for the survival of fully differentiated plasma cells 52 . However, Blimp-1-deficient plasma cells lost their ability to secrete antibodies 52 . Moreover, many Blimp-1 target genes, identified here in pre-plasmablasts, were also deregulated after the loss of Blimp-1 in plasma cells, which indicated that their expression depends on Blimp-1 throughout terminal plasma cell differentiation 52 .
The transcription factor XBP-1 is essential for the efficient secretion of antibody by plasma cells 5 . As shown here, Xbp1 transcription was substantially activated in a Blimp-1-dependent manner in plasmablasts, although we were unable to detect Blimp-1-binding sites in the vicinity of Xbp1. It is therefore conceivable that Xbp1 is indirectly activated by the UPR 3 , which is induced by the increased synthesis of secreted immunoglobulin in plasmablasts.
IRF4 is another essential regulator of plasma-cell development 7 that is known to bind to and activate Prdm1 at the onset of plasmablast differentiation 9, 10 . Here we identified Irf4 as one of seven Blimp-1-activated transcription factor-encoding genes that was directly activated by Blimp-1 even in the absence of protein synthesis in WEHI-Blimp-1-ER T2 cells. Hence, Blimp-1 and IRF4 cross-regulate each other's expression in antibody-secreting cells. IRF4 recognizes its motif (5′-GAAA-3′) with high affinity only upon cooperative binding with PU.1 to the EICE 31 or with the BATF-Jun complex to the AP1-IRF composite element 53 . Interestingly, the IRF4-recognition sequence was also present in the Blimp-1-binding motif. Moreover, half of all Blimp-1 peaks overlapped IRF4 and PU.1 peaks in plasmablasts, while a subset of these peaks had a common binding site for Blimp-1 and the PU.1-IRF4 complex. However, this common binding site was bound by Blimp-1 and the PU.1-IRF4 complex in a mutually exclusive manner, which excluded the possibility that Blimp-1 and IRF4 cooperatively bind to DNA.
Our identification of regulated Blimp-1 target genes that encode proteins with functions in cell adhesion and migration has defined a previously unknown Blimp-1-regulated pathway. Blimp-1 repressed 23 genes encoding chemokine receptors (Ackr2 and Ccr7), celladhesion proteins (Cd37, Chd17, Itgam and Sell), intracellular adaptors (Ahnak, Nckipsd and Pstpip1), GTPase-activating proteins (Arhgap17, Arhgap24 and Asap1), GTPases (Gbp1 and Gbp2), a guanine nucleotide-exchange factor (Fdg2), a kinase (Hck), a metabolic enzyme (St3gal6), an E3 ligase subunit (Asb2) and cytoskeletonassociated proteins (Evl, Gsn, Myo1e, Rcsd1 and Tmsb4x). Blimp-1 also activated 9 genes encoding cell-surface proteins (Alcam and Ccrl2), intracellular adaptors (Nck2, Rasip1 and Tns3), GTPaseactivating proteins (Dab2ip and Evi5), a guanine nucleotide-binding protein (Gnaz) and an actin-bundling molecule (Pls1). Consistent with these expression changes, Blimp-1 controlled the increased migration and adhesion of plasmablasts compared with that of activated B cells, which might explain the reported migratory and sessile activity of plasmablasts and plasma cells in the spleen 30 , lymph nodes 29, 30 and bone marrow 29, 30 .
At the chromatin level, Blimp-1 induced the rapid loss of active histone modifications and a delayed gain of the repressive mark H3K27me3 at binding sites of repressed target genes. The spreading of H3K27me3 from these Blimp-1-binding sites strictly depended on Blimp-1 but did not require the presence of a CpG island. That finding is incompatible with the prevailing model that the H3K27-methylating PRC2 complex is recruited by default to CpG islands lacking active chromatin 43 . Instead, we found that Blimp-1 npg bound to and recruited the PRC2 complex to Blimp-1-binding sites at repressed target genes in an 'instructive' manner. In addition to interacting with PRC2, Blimp-1 has been shown, mainly in non-B lymphoid cell types, to interact with proteins of the Groucho family 18 , histone deacetylases 19 , the H3K9 methyltransferase G9a 17 and the H3K4 demethylase LSD1 (ref. 16 ), which might act as co-repressors to mediate Blimp-1-dependent gene silencing. Here we discovered a different set of Blimp-1-interacting complexes in plasmablasts by Blimp-1-Bio precipitation experiments through the use of mass spectrometry to identify subunits of the chromatinremodeling BAF complex 45 and NuRD complex 45 as well as of the histone-deacetylating NCoR co-repressor complex 46 and SIN3 co-repressor complex 46 . Notably, Blimp-1 rapidly recruited these complexes to its binding sites at repressed target genes in WEHI-Blimp-1-ER T2 cells. Hence, Blimp-1 repressed its target genes in plasmablasts and plasma cells by recruiting chromatin-remodeling and histonemodifying complexes to its binding sites.
METHODS
Methods and any associated references are available in the online version of the paper.
